(-0.03%) 5 306.50 points
(0.02%) 40 154 points
(-0.03%) 18 498 points
(1.54%) $82.60
(0.06%) $1.719
(1.02%) $2 235.30
(-0.18%) $24.71
(0.24%) $911.85
(0.39%) $0.927
(0.72%) $10.85
(0.13%) $0.792
(-0.14%) $92.31
Live Chart Being Loaded With Signals
BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation...
Stats | |
---|---|
Today's Volume | 228 725 |
Average Volume | 358 593 |
Market Cap | 3.26B |
EPS | SEK0 ( 2024-02-19 ) |
Next earnings date | ( SEK-1.050 ) 2024-05-01 |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -1.960 |
ATR14 | SEK0.177 (0.38%) |
Volume Correlation
BICO Group AB (publ) Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
BICO Group AB (publ) Correlation - Currency/Commodity
BICO Group AB (publ) Financials
Annual | 2022 |
Revenue: | SEK2.24B |
Gross Profit: | SEK1.83B (81.74 %) |
EPS: | SEK-12.99 |
Q3 | 2023 |
Revenue: | SEK587.20M |
Gross Profit: | SEK429.20M (73.09 %) |
EPS: | SEK-1.000 |
Q2 | 2023 |
Revenue: | SEK541.10M |
Gross Profit: | SEK372.20M (68.79 %) |
EPS: | SEK-12.73 |
Q1 | 2023 |
Revenue: | SEK500.70M |
Gross Profit: | SEK389.40M (77.77 %) |
EPS: | SEK-1.680 |
Financial Reports:
No articles found.
BICO Group AB (publ)
BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators